Detalles de la búsqueda
1.
A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease.
Am J Hematol
; 87(11): 1017-21, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22887019
2.
Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy.
Eur Heart J
; 32(19): 2412-9, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21724623
3.
A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR Phase IIb trial.
Am Heart J
; 161(2): 261-268.e1-2, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21315207
4.
Novel therapeutic candidates, identified by molecular modeling, induce γ-globin gene expression in vivo.
Blood Cells Mol Dis
; 47(2): 107-16, 2011 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21641240
5.
Pharmacokinetics of ADS-5102 (Amantadine) Extended Release Capsules Administered Once Daily at Bedtime for the Treatment of Dyskinesia.
Clin Pharmacokinet
; 58(1): 77-88, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29777529
6.
Transient CDK4/6 inhibition protects hematopoietic stem cells from chemotherapy-induced exhaustion.
Sci Transl Med
; 9(387)2017 04 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-28446688
7.
Evaluation of safety and pharmacokinetics of sodium 2,2 dimethylbutyrate, a novel short chain fatty acid derivative, in a phase 1, double-blind, placebo-controlled, single-dose, and repeat-dose studies in healthy volunteers.
J Clin Pharmacol
; 51(8): 1186-94, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21422239
Resultados
1 -
7
de 7
1
Próxima >
>>